Learn about treatments for OA knee pain. Watch video.

Mobic Tablets

Pronunciation

Generic Name: meloxicam
Dosage Form: tablet

Mobic® (meloxicam) tablets
Initial U.S. Approval: 2000

Mobic (meloxicam) Tablets
7.5 mg
100 tablets
NDC: 64674-029-01

Mobic (meloxicam) Tablets
15 mg
100 tablets
NDC: 64674-030-01

MOBIC 
meloxicam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:64674-029
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Meloxicam (Meloxicam) Meloxicam 7.5 mg
Product Characteristics
Color YELLOW Score no score
Shape ROUND Size 8mm
Flavor Imprint Code ;M
Contains         
Packaging
# Item Code Package Description
1 NDC:64674-029-01 100 TABLET in 1 BOTTLE, PLASTIC
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020938 06/01/2000
MOBIC 
meloxicam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:64674-030
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Meloxicam (Meloxicam) Meloxicam 15 mg
Product Characteristics
Color YELLOW Score no score
Shape OVAL (Oblong) Size 11mm
Flavor Imprint Code M;15
Contains         
Packaging
# Item Code Package Description
1 NDC:64674-030-01 100 TABLET in 1 BOTTLE, PLASTIC
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020938 10/01/2000
Labeler - Boehringer Ingelheim Promeco S.A. de C.V. (812579472)
Registrant - Boehringer Ingelheim Pharmaceuticals, Inc. (603175944)
Establishment
Name Address ID/FEI Operations
Boehringer Ingelheim Promeco S.A. de C.V. 812579472 MANUFACTURE(64674-029, 64674-030)
Revised: 05/2013
 
Boehringer Ingelheim Promeco S.A. de C.V.



Got questions about Rheumatoid Arthritis? Get answers from our expert Dr. Carteron. Click Here

Close
Hide
(web1)